• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用聚合物沉淀抑制剂提高疏水性药物的吸收:实用的机制基础。

Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.

机构信息

Medicinal Chemistry and Drug Action, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.

出版信息

J Drug Target. 2010 Dec;18(10):704-31. doi: 10.3109/1061186X.2010.525652. Epub 2010 Oct 26.

DOI:10.3109/1061186X.2010.525652
PMID:20973755
Abstract

The inclusion of certain polymers within solid dispersion or lipid-based formulations can maintain drug supersaturation after dispersion and/or digestion of the vehicle, leading to improvements in bioavailability and variability in exposure. This review presents an overview of the fundamental principles that underpin drug precipitation mechanisms, describes the mechanisms by which precipitation may be inhibited, discusses the methods that can be used to identify polymeric precipitation inhibitors (PPIs), and summarizes current literature evidence of the most effective PPIs. Preliminary data from our laboratory is also presented, which describes the precipitation inhibition behavior of 53 polymeric materials using supersaturated solutions of danazol as a model, poorly water-soluble drug. These studies identify a group of PPIs with superior precipitation inhibition qualities, the majority of which are cellulose-based. These new results in combination with previous published data indicate that PPIs represent an appealing new technology with the potential to improve drug absorption for poorly water-soluble drugs. The molecular determinants of polymer utility, however, remain relatively poorly understood, although the cellulose derivates appear, in general, to provide the most benefit. More detailed studies are therefore required to define the parameters that most effectively predict and quantify the drug-polymer relationships that control precipitation inhibition.

摘要

某些聚合物在固体分散体或基于脂质的制剂中的存在可以在载体分散和/或消化后维持药物过饱和状态,从而提高生物利用度和暴露的可变性。本综述介绍了支持药物沉淀机制的基本原理概述,描述了可能抑制沉淀的机制,讨论了可以用来识别聚合物沉淀抑制剂(PPI)的方法,并总结了最有效 PPI 的当前文献证据。我们实验室的初步数据也被提出,该数据描述了使用作为模型的丹那唑过饱和溶液的 53 种聚合物材料的沉淀抑制行为,丹那唑是一种水溶性差的药物。这些研究确定了一组具有卓越沉淀抑制特性的 PPI,其中大多数是基于纤维素的。这些新结果与之前发表的数据表明,PPI 代表了一种有吸引力的新技术,有可能改善水溶性差的药物的药物吸收。然而,聚合物用途的分子决定因素仍然相对了解甚少,尽管纤维素衍生物通常提供最大的益处。因此,需要进行更详细的研究来定义最有效地预测和量化控制沉淀抑制的药物-聚合物关系的参数。

相似文献

1
Using polymeric precipitation inhibitors to improve the absorption of poorly water-soluble drugs: A mechanistic basis for utility.使用聚合物沉淀抑制剂提高疏水性药物的吸收:实用的机制基础。
J Drug Target. 2010 Dec;18(10):704-31. doi: 10.3109/1061186X.2010.525652. Epub 2010 Oct 26.
2
Evaluation of the structural determinants of polymeric precipitation inhibitors using solvent shift methods and principle component analysis.采用溶剂位移法和主成分分析法评价聚合物沉淀抑制剂的结构决定因素。
Mol Pharm. 2013 Aug 5;10(8):2823-48. doi: 10.1021/mp300576u. Epub 2013 Jul 2.
3
Drug precipitation inhibitors in supersaturable formulations.药物增溶剂在过饱和制剂中的应用。
Int J Pharm. 2013 Aug 30;453(1):36-43. doi: 10.1016/j.ijpharm.2013.05.013. Epub 2013 May 13.
4
Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.聚合物沉淀抑制剂促进非诺贝特过饱和并增强 IV 型脂肪乳剂配方的药物吸收。
Mol Pharm. 2018 Jun 4;15(6):2355-2371. doi: 10.1021/acs.molpharmaceut.8b00206. Epub 2018 May 4.
5
Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo.Soluplus® 作为一种有效的吸收促进剂,可提高体内外难溶性药物的溶解度。
Eur J Pharm Sci. 2012 Feb 14;45(3):336-43. doi: 10.1016/j.ejps.2011.11.025. Epub 2011 Dec 8.
6
Lipid digestion as a trigger for supersaturation: evaluation of the impact of supersaturation stabilization on the in vitro and in vivo performance of self-emulsifying drug delivery systems.脂质消化作为过饱和的触发因素:评价过饱和度稳定对自乳化药物传递系统的体内外性能的影响。
Mol Pharm. 2012 Jul 2;9(7):2063-79. doi: 10.1021/mp300164u. Epub 2012 Jun 15.
7
Impact of polymers on the precipitation behavior of highly supersaturated aqueous danazol solutions.聚合物对高度过饱和达那唑水溶液沉淀行为的影响。
Mol Pharm. 2014 Sep 2;11(9):3027-38. doi: 10.1021/mp500201s. Epub 2014 Aug 14.
8
Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.通过体外动态脂解模型优化口服脂质体药物递送系统的选择,以提高难溶性药物的口服生物利用度。
J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1.
9
pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs.pH 敏感型聚合物纳米粒提高肽/蛋白类药物和难溶性药物的口服生物利用度。
Eur J Pharm Biopharm. 2012 Oct;82(2):219-29. doi: 10.1016/j.ejpb.2012.07.014. Epub 2012 Aug 3.
10
Toward the establishment of standardized in vitro tests for lipid-based formulations. 2. The effect of bile salt concentration and drug loading on the performance of type I, II, IIIA, IIIB, and IV formulations during in vitro digestion.为了建立标准化的基于脂质的制剂的体外测试方法。2. 胆汁盐浓度和药物载药量对 I 型、II 型、IIIA 型、IIIB 型和 IV 型制剂在体外消化过程中的性能的影响。
Mol Pharm. 2012 Nov 5;9(11):3286-300. doi: 10.1021/mp300331z. Epub 2012 Oct 22.

引用本文的文献

1
Combination Drug Product of Amorphous Solid Dispersion Show Extended Supersaturation and Enhanced Dissolution.无定形固体分散体组合药物产品显示出延长的过饱和和增强的溶解。
AAPS PharmSciTech. 2025 May 30;26(5):152. doi: 10.1208/s12249-025-03126-3.
2
Influence of Ionization and the Addition of Cyclodextrins and Hydrophilic Excipients on the Solubility of Benzthiazide, Isoxicam, and Piroxicam.电离以及环糊精与亲水性辅料的添加对苄噻嗪、异恶酰胺和吡罗昔康溶解度的影响。
Pharmaceutics. 2025 Apr 25;17(5):571. doi: 10.3390/pharmaceutics17050571.
3
Lipid-encapsulated gold nanoparticles: an advanced strategy for attenuating the inflammatory response in SARS-CoV-2 infection.
脂质包裹的金纳米颗粒:一种减轻SARS-CoV-2感染中炎症反应的先进策略。
J Nanobiotechnology. 2025 Jan 15;23(1):15. doi: 10.1186/s12951-024-03064-5.
4
Formulating abiraterone acetate-HPMCAS-based amorphous solid dispersions: insights into and biorelevant dissolution assessments and pharmacokinetic evaluations.基于醋酸阿比特龙-羟丙基甲基纤维素醋酸琥珀酸酯的无定形固体分散体的制备:深入了解及与生物相关的溶出度评估和药代动力学评价
RSC Adv. 2024 Dec 5;14(52):38492-38505. doi: 10.1039/d4ra08163c. eCollection 2024 Dec 3.
5
Amorphous Solid Dispersion Formation for Enhanced Release Performance of Racemic and Enantiopure Praziquantel.无定形固体分散体形成增强消旋和对映纯吡喹酮的释放性能。
Mol Pharm. 2024 Oct 7;21(10):5285-5296. doi: 10.1021/acs.molpharmaceut.4c00711. Epub 2024 Sep 18.
6
Phase homogeneity in ternary amorphous solid dispersions and its impact on solubility, dissolution and supersaturation - Influence of processing and hydroxypropyl cellulose grade.三元无定形固体分散体的相均匀性及其对溶解度、溶出度和过饱和度的影响——加工工艺和羟丙基纤维素等级的影响
Int J Pharm X. 2023 Dec 2;6:100222. doi: 10.1016/j.ijpx.2023.100222. eCollection 2023 Dec 15.
7
Comparative analysis of drug-salt-polymer interactions by experiment and molecular simulation improves biopharmaceutical performance.通过实验和分子模拟对药物-盐-聚合物相互作用进行比较分析可改善生物制药性能。
Commun Chem. 2023 Sep 25;6(1):201. doi: 10.1038/s42004-023-01006-0.
8
Emerging Applications of Hydroxypropyl Methylcellulose Acetate Succinate: Different Aspects in Drug Delivery and Its Commercial Potential.羟丙甲纤维素琥珀酸酯的新兴应用:药物传递中的不同方面及其商业潜力。
AAPS PharmSciTech. 2023 Sep 15;24(7):188. doi: 10.1208/s12249-023-02645-1.
9
Influence of Polyvinylpyrrolidone Molecular Weight and Concentration on the Precipitation Inhibition of Supersaturated Solutions of Poorly Soluble Drugs.聚乙烯吡咯烷酮分子量和浓度对难溶性药物过饱和溶液沉淀抑制的影响
Pharmaceutics. 2023 May 26;15(6):1601. doi: 10.3390/pharmaceutics15061601.
10
The Development of Super-Saturated Rebamipide Eye Drops for Enhanced Solubility, Stability, Patient Compliance, and Bioavailability.用于提高溶解度、稳定性、患者顺应性和生物利用度的超饱和瑞巴派特滴眼液的研发
Pharmaceutics. 2023 Mar 15;15(3):950. doi: 10.3390/pharmaceutics15030950.